Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	6 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Operating activities:
Net earnings	$ 243	$ 297
Adjustments to reconcile net earnings to net cash provided by operations:
Depreciation and amortization	111	107
Stock-based compensation	34	40
Deferred income taxes	92	(19)
Loss on divestiture	0	112
Other	(16)	5
Changes in:
Receivables, net	156	64
Inventories, net	(83)	(12)
Prepaid expenses and other current assets	(30)	(39)
Accounts payable and accrued liabilities	(6)	(138)
Operating lease right-of-use assets and liabilities, net	(4)	0
Income taxes payable / prepaid	(93)	(16)
Net cash provided by operations	404	401
Investing activities:
Capital expenditures	(78)	(92)
Proceeds from divestiture, net of cash divested	0	128
Other	1	(1)
Net cash (used for) provided by investing activities	(77)	35
Financing activities:
Notes and loans payable, net	303	184
Treasury stock purchased	(256)	(257)
Cash dividends paid to Clorox stockholders	(302)	(302)
Issuance of common stock for employee stock plans and other	(14)	29
Net cash used for financing activities	(269)	(346)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	1	(3)
Net increase (decrease) in cash, cash equivalents and restricted cash	59	87
Cash, cash equivalents and restricted cash:
Beginning of period	170	207
End of period	$ 229	$ 294